Cetera Trust Company’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.24K Hold
1,500
– – ﹤0.01% 318
2026
Q2
$8.13K Hold
1,500
– – ﹤0.01% 309
2026
Q1
$3.42K Hold
1,500
– – ﹤0.01% 343
2025
Q4
$6K Sell
1,500
-8,225
-85% -$45.7K ﹤0.01% 332
2025
Q3
$82.3K Hold
9,725
– – 0.05% 208
2025
Q2
$110K Buy
9,725
+3,125
+47% +$28.7K 0.07% 198
2025
Q1
$62.5K Hold
6,600
– – 0.04% 216
2024
Q4
$74.2K Sell
6,600
-2,730
-29% -$48K 0.05% 206
2024
Q3
$264K Buy
9,330
+220
+2% +$5.67K 0.16% 127
2024
Q2
$174K Hold
9,110
– – 0.11% 173
2024
Q1
$299K Sell
9,110
-50
-0.5% -$1.6K 0.18% 100
2023
Q4
$303K Buy
+9,160
New +$259K 0.19% 94

Other funds holding EVH

Cetera Trust Company's EVH Position: Q3 2026 in Review

Cetera Trust Company held its Evolent Health (EVH) position steady in Q3 2026 at 1,500 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Cetera Trust Company first reported a position in EVH in Q4 2023 and has held it in 12 quarters since. The position peaked at $303K in Q4 2023. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Cetera Trust Company held 1,500 shares of Evolent Health worth $5.24K as of Q3 2026.
  • Cetera Trust Company left its Evolent Health share count unchanged in Q3 2026.
  • Evolent Health made up ﹤0.01% of Cetera Trust Company's portfolio in Q3 2026, its #318 holding.
  • Cetera Trust Company first reported a position in Evolent Health in Q4 2023 and has held it in 12 quarters since.
  • Cetera Trust Company's Evolent Health position peaked at $303K in Q4 2023.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Cetera Trust Company's 13F filing for Q3 2026, filed 9 Nov 2026.